DATALEC
18.7.2022 12:02:09 CEST | Business Wire | Press release
Datalec Precision Installations (DPI) , a provider of world-class data centre design, supply, build and support services to deliver seamless, integrated and unified end-to-end solutions for data centre operators, is pleased to announce that the company has won the DCS Award for Data Centre Consolidation/Upgrade Project of the Year Award . The DCS Awards recognise and congratulate data centre industry innovation with 30 award categories across four groups.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220718005143/en/
DPI was honoured with the award and was applauded for updating a 60k square foot data centre facility that had an outdated optical connectivity design. The facility’s design resulted in cabling containment constraints which conversely restricted its ability to connect end customers data suites to meet with service level agreements. Through innovative design solutions, DPI reverse engineered the project to effectively navigate old building infrastructure. The DPI team provided a bespoke end-to-end secure containment design enabling protection for the implementation and distribution of a new ODF fibre cabling solution. The project delivered a proactive approach for the customer requiring agility, flexibility and adaptability for this substantial data centre project.
As a direct result of DPI’s bespoke solution, the data centre facility is now capable of delivering services within industry standard SLAs. Furthermore, the facility has the ability to scale colocation environments or provide larger suites to suit various client requirements. “Our solution provided our customer with the flexibility and upgradeability required by all their current and future customers, and we are honoured to have been awarded this prestigious acknowledgement. I couldn’t be prouder of the hard work and dedication that our containment and connectivity teams provided to this project,” said Lee Eiffert, COO at DPI. “We pride ourselves on our first-class customer service, One Call, One Team.”
As a result of significant business growth and to better serve its customers, over the past 12 months DPI has embarked on a substantial recruitment drive. Within the DPI connectivity team, new employees include managed service mobile engineers, project managers, apprentices and trainee engineers. Furthermore, DPI remains committed to investing in and nurturing young talent through its professional development programme and CNET’s training programmes.
Such is the scale of its project delivery that over the past 12 months, the length of single core fibre cabling installed during its UK and European projects equates to almost 4 million metres, the equivalent of over twice the distance between the FLAP city markets or 435 times the height of Mount Everest!
To learn more about Datalec Precision Installations (DPI), visit https://datalecltd.com
About Datalec
Datalec Precision Installations delivers excellence in international data centre installations, partnering with clients to make their businesses successful while providing seamless, integrated, unified end-to-end results with a ‘One Call, One Team’ service. DPI’s rigorous project management and supervision ensures projects are implemented to perfection the first time, every time, while mitigating risk and reducing cost for clients. DPI is focused on delivering a proactive and personal service that provides agility, flexibility and adaptability for substantial data suite construction and implementations. For more information visit: https://datalecltd.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20220718005143/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press release
Newest expansion of the NetBrain platform delivers Agent Skills, AI Path Doctor, MCP Server, and expanded cross-domain integrations, extending the agentic capabilities already running in production at hundreds of enterprises. NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press release
News summary: Non-practicing entity litigation continues to create costly, time-consuming pressure across the technology industry Adtran has reached a full settlement following counterclaims, with payment made to Adtran and all claims dismissed with prejudice Outcome reflects Adtran’s commitment to defend its innovations, customers and business against meritless patent assertions Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consi
Meiji Seika Pharma Invests in GHIC’s Global Health Security Fund29.5.2026 13:00:00 CEST | Press release
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) today announced that it has committed to invest in the Global Health Security Fund (GHSF), which is sponsored by Global Health Investment Corporation (GHIC), a New York-based nonprofit organization. Through this investment, Meiji Seika Pharma will support the acceleration of innovations addressing critical global health challenges, including pandemic preparedness and antimicrobial resistance (AMR). GHIC is a mission‑driven nonprofit organization that deploys private investment strategies to generate both global health impact and financial returns. GHIC recently closed its second fund in GHSF. With more than a decade of experience investing in the field of infectious disease, GHIC has contributed to addressing major global health challenges. Its portfolio companies have successfully commercialized more than a dozen products, collectively reaching over 600 million people wo
IFF Enters Into Agreement to Sell Its Food Ingredients Business to CVC29.5.2026 12:50:00 CEST | Press release
Transaction advances portfolio transformation, sharpens focus on higher-growth, higher-margin businesses, strengthens balance sheet, and enhances value creation for shareholders IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients, and health and biosciences, today announced that it has entered into an agreement to sell its Food Ingredients business to funds advised by CVC Capital Partners, a leading global private markets manager, in a transaction that values the business at approximately $4.3 billion, representing an enterprise value-to-EBITDA multiple of approximately 10x. As part of the transaction, IFF has chosen to retain an approximately 10% minority equity interest in the business, or approximately $200 million, permitting continued collaboration and cooperation between IFF and Food Ingredients and allowing IFF and its shareholders to participate in future value creation under its new ownership. The transaction marks a significant step in IFF’s portfolio tr
BeOne Medicines Establishes Standard for Long-Term Disease Control in CLL with BRUKINSA 78-Month Data at ASCO 202629.5.2026 12:00:00 CEST | Press release
Data represents the longest reported follow-up for a next-generation BTK inhibitor in CLL, showing sustained disease control and benefit that extends beyond first-line therapyBRUKINSA plus next-generation BCL2 inhibitor sonrotoclax (ZS) delivered deep, durable, and rapid uMRD responses, raising the bar for potential time-limited treatments in CLLData reinforce BeOne’s leadership in CLL and the strength of its foundational hematology franchise BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, is advancing the treatment paradigm in chronic lymphocytic leukemia (CLL) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. With extensive long-term follow-up, the SEQUOIA study of BRUKINSA® (zanubrutinib) reinforces its role as the foundational BTK inhibitor, showing sustained disease control over years of therapy. These findings are further supported by real-world evidence across three large analyses encompassing more than 250,000 pati
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
